My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 148

    1.

    Thiazolidinediones and heart failure: a teleo-analysis.

    Singh S, Loke YK, Furberg CD.

    Diabetes Care. 2007 Aug;30(8):2148-53. Epub 2007 May 29.PMID: 17536074 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.

    Lago RM, Singh PP, Nesto RW.

    Lancet. 2007 Sep 29;370(9593):1129-36. Review.PMID: 17905165 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

    Lincoff AM, Wolski K, Nicholls SJ, Nissen SE.

    JAMA. 2007 Sep 12;298(10):1180-8.PMID: 17848652 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

    Singh S, Loke YK, Furberg CD.

    JAMA. 2007 Sep 12;298(10):1189-95.PMID: 17848653 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure.

    Granberry MC, Hawkins JB, Franks AM.

    Am J Health Syst Pharm. 2007 May 1;64(9):931-6. Review.PMID: 17468147 [PubMed - indexed for MEDLINE]Related articles

    6.

    Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?

    Patel C, Wyne KL, McGuire DK.

    Diab Vasc Dis Res. 2005 May;2(2):61-6. Review.PMID: 16305060 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials]

    De Flines J, Scheen AJ.

    Rev Med Suisse. 2007 Aug 29;3(122):1876, 1878-83. Review. French. PMID: 17896661 [PubMed - indexed for MEDLINE]Related articles

    8.

    Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.

    Dahabreh IJ, Economopoulos K.

    Clin Trials. 2008;5(2):116-20. Erratum in: Clin Trials. 2008;5(5):559. Economopoulos, K [added]. PMID: 18375649 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

    Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA; PROactive investigators.

    Diabetes Care. 2007 Nov;30(11):2773-8. Epub 2007 Jul 31.PMID: 17666462 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Thiazolidinediones in patients with diabetes mellitus and heart failure : implications of emerging data.

    Macfarlane DP, Fisher M.

    Am J Cardiovasc Drugs. 2006;6(5):297-304. Review.PMID: 17083264 [PubMed - indexed for MEDLINE]Related articles

    11.

    Do thiazolidinediones cause heart failure? A critical review.

    Tang WH.

    Cleve Clin J Med. 2006 Apr;73(4):390-7. Review. Erratum in: Cleve Clin J Med. 2006 Jun;73(6):588. PMID: 16610400 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.

    Koro CE, Sowell MO, Stender M, Qizilbash N.

    Clin Ther. 2008 Mar;30(3):535-42.PMID: 18405791 [PubMed - indexed for MEDLINE]Related articles

    13.

    Possible heart failure exacerbation associated with rosiglitazone: case report and literature review.

    Page RL 2nd, Gozansky WS, Ruscin JM.

    Pharmacotherapy. 2003 Jul;23(7):945-54. Review.PMID: 12885108 [PubMed - indexed for MEDLINE]Related articles

    14.

    Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.

    Lipscombe LL, Gomes T, Lévesque LE, Hux JE, Juurlink DN, Alter DA.

    JAMA. 2007 Dec 12;298(22):2634-43.PMID: 18073359 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Type 2 diabetes, thiazolidinediones, and cardiovascular risk.

    Taylor C, Hobbs FD.

    Br J Gen Pract. 2009 Jul;59(564):520-4.PMID: 19567003 [PubMed - indexed for MEDLINE]Related articles

    16.

    Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study.

    Hartung DM, Touchette DR, Bultemeier NC, Haxby DG.

    Pharmacotherapy. 2005 Oct;25(10):1329-36.PMID: 16185176 [PubMed - indexed for MEDLINE]Related articles

    17.

    Considerations for management of fluid dynamic issues associated with thiazolidinediones.

    Hollenberg NK.

    Am J Med. 2003 Dec 8;115 Suppl 8A:111S-115S. Review.PMID: 14678876 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of the thiazolidinedione medications on micro- and macrovascular complications in patients with diabetes--update 2008.

    Rohatgi A, McGuire DK.

    Cardiovasc Drugs Ther. 2008 Jun;22(3):233-40. Epub 2008 Mar 29. Review.PMID: 18373186 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pioglitazone initiation and subsequent hospitalization for congestive heart failure.

    Karter AJ, Ahmed AT, Liu J, Moffet HH, Parker MM.

    Diabet Med. 2005 Aug;22(8):986-93.PMID: 16026362 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study.

    Delea TE, Edelsberg JS, Hagiwara M, Oster G, Phillips LS.

    Diabetes Care. 2003 Nov;26(11):2983-9.PMID: 14578227 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity